---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-074745"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2023-06-26T23:59:59+00:00"
generated_at: "2026-06-13T17:05:43.541628+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics stockholders elect six directors, ratify KPMG, approve say-on-pay at 3-year frequency

## Summary
- All six director nominees elected with >9.5M votes each; broker non-votes ~1.37M.
- Ratification of KPMG as auditor for FY2023 passed with 10.8M for, 246K against.
- Advisory vote on executive compensation approved with 9.5M for, 128K against.
- Say-on-pay frequency set at every 3 years on advisory basis (9.4M votes for 3 years).
- Meeting held virtually June 22, 2023; quorum achieved with majority voting power.

## SEC filing metadata
- accession: 0001104659-23-074745
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2023-06-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465923074745/0001104659-23-074745-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465923074745/tm2319602d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-074745
- JSON: https://secwatch.observer/filing/0001104659-23-074745.json
- Plain text: https://secwatch.observer/filing/0001104659-23-074745.txt

## Key facts
- Shareholder Votes
  AVENUE THERAPEUTICS, INC. shareholders approved Election of six directors to hold office until the 2024 annual meeting of stockholders at the 2023-06-22 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-22
  source text: The votes with respect to the election of six directors to hold office until the 2024 annual meeting of stockholders were as follows: Director Votes For Votes Withheld Broker Non-Votes Jay Kranzler, M.D., Ph.D. 9,598,212 104,822 1,374,581 Faith Charles 9,603,663 99,371 1,374,581 Neil Herskowitz 9,602,391 100,643 1,374,581 Alexandra MacLean, M.D. 9,598,851 104,183 1,374,581 Curtis Oltmans 9,603,075 99,959 1,374,581 Lindsay A. Rosenwald, M.D. 9,544,216 158,818 1,374,581
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465923074745/0001104659-23-074745-index.htm
- Shareholder Votes
  AVENUE THERAPEUTICS, INC. shareholders approved Non-binding advisory vote to approve compensation of named executive officers at the 2023-06-22 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-22
  source text: The vote, on a non-binding advisory basis, to approve the compensation of the Company’s named executive officers was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 9,541,965 128,472 32,597 1,374,581
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465923074745/0001104659-23-074745-index.htm
- Shareholder Votes
  AVENUE THERAPEUTICS, INC. shareholders approved Ratify the selection of KPMG LLP as independent registered accounting firm for the year ending December 31, 2023 at the 2023-06-22 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-22
  source text: The vote on the proposal to ratify the selection of KPMG LLP as Avenue’s independent registered accounting firm for the year ending December 31, 2023 was as follows: Total Votes For Total Votes Against Abstentions 10,823,449 245,962 8,204
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465923074745/0001104659-23-074745-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.